umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Towards novel antibacterials: Synthesis and identification of natural product inspired inhibitors of Chlamydia trachomatis and development of chemical probes targeting virulence of Pseudomonas aeruginosa
Umeå universitet, Teknisk-naturvetenskapliga fakulteten, Kemiska institutionen. (Mikael Elofsson's group)
2018 (Engelska)Doktorsavhandling, sammanläggning (Övrigt vetenskapligt)
Abstract [en]

Antibiotic resistance has evolved significantly to become one of the serious threats to public health today. Yet, the pipeline of new antibiotics is drying up and is lagging behind the challenging needs. As a contribution to this recurrent need for novel antibacterials, we applied multidisciplinary strategies to identify small-molecule antibacterials against Chlamydia trachomatis and antivirulence agents against Pseudomonas aeruginosa infections. These strategies included:

1. Synthesis of a focused compounds library inspired by natural product scaffolds followed by phenotypic screening against Chlamydia trachomatis. (Paper I)

(-)-Hopeaphenol is a polyphenol natural product that was identified as an antivirulence agent against Y. pseudotuberculosis and P. aeruginosa. Hopeaphenol core scaffold, 2,3-diaryl-2,3-dihydrobenzofuran, is ubiquitous in polyphenolic phytochemicals. In this thesis, a focused library of forty-eight compounds was synthesized based on 2,3-diarylbenzofuran and 2,3-diaryl-2,3- dihydrobenzofuran. The library was then explored for antibacterial properties in a number of screening assays and resulted in five novel antichlamydial compounds with inhibition potency down to sub-micromolar. The identified molecules also inhibited the growth of different clinical presentations of C. trachomatis, one of the most common sexually transmitted disease worldwide.

2. Target-based screening against the P. aeruginosa virulence factor using enzymatic and biophysical assays. (Paper II-IV)

P. aeruginosa is a Gram-negative opportunistic pathogen with remarkable antibiotic resistance that is associated with a wide range of clinical infections. An alternative strategy to develop novel and selective antibacterials is to target the bacterial virulence factors, i.e. the ability of the bacteria to promote disease, thus ‘disarming’ the pathogens instead of killing them. P. aeruginosa employs its virulence factor, the type III secretion system (T3SS), to inject toxins (e.g. ExoS) into the eukaryotic cytosol. In one part of this thesis, we utilized enzymatic assay and identified inhibitors against the P. aeruginosa T3S toxin (ExoS). A follow up structure-activity relationship analysis was established and resulted in five (low micromolar) inhibitors of ExoS ADP-ribosylation enzymatic activity. In another part, we used surface plasmon resonance biophysical assay and identified small molecule binders of T3S translocation protein (PcrV). The primary SAR analysis was established and showed the antivirulence properties of these molecules and the potential to expand them further as novel antibacterials.

Ort, förlag, år, upplaga, sidor
Umeå: Umeå University , 2018. , s. 95
Nyckelord [en]
Antibacterials, antibiotics, small molecules, natural products, benzofuran, dihydrobenzofuran, the type III secretion system, Pseudomonas aeruginosa, Chlamydia trachomatis, phenotypic screening, high-throughput screening, surface plasmon resonance, drug discovery, bacterial toxins, enzyme inhibitors
Nationell ämneskategori
Naturvetenskap Organisk kemi
Forskningsämne
organisk kemi
Identifikatorer
URN: urn:nbn:se:umu:diva-150970ISBN: 978-91-7601-917-7 (tryckt)OAI: oai:DiVA.org:umu-150970DiVA, id: diva2:1240446
Disputation
2018-09-14, KB.E3.03 (Stora hörsalen), KBC-huset, Umeå, 09:00 (Engelska)
Opponent
Handledare
Forskningsfinansiär
Stiftelsen för strategisk forskning (SSF), SSF, SB12-0022Tillgänglig från: 2018-08-24 Skapad: 2018-08-21 Senast uppdaterad: 2018-08-21Bibliografiskt granskad
Delarbeten
1. Natural product inspired library synthesis – Identification of 2,3-diarylbenzofuran and 2,3-dihydrobenzofuran based inhibitors of Chlamydia trachomatis
Öppna denna publikation i ny flik eller fönster >>Natural product inspired library synthesis – Identification of 2,3-diarylbenzofuran and 2,3-dihydrobenzofuran based inhibitors of Chlamydia trachomatis
Visa övriga...
2018 (Engelska)Ingår i: European Journal of Medicinal Chemistry, ISSN 0223-5234, E-ISSN 1768-3254, Vol. 143, s. 1077-1089Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

A natural product inspired library was synthesized based on 2,3-diarylbenzofuran and 2,3-diaryl-2,3-dihydrobenzofuran scaffolds. The library of forty-eight compounds was prepared by utilizing Pd-catalyzed one-pot multicomponent reactions and ruthenium-catalyzed intramolecular carbenoid C-H insertions. The compounds were evaluated for antibacterial activity in a panel of test systems including phenotypic, biochemical and image-based screening assays. We identified several potent inhibitors that block intracellular replication of pathogenic Chlamydia trachomatis with IC50 ≤ 3 μM. These new C. trachomatis inhibitors can serve as starting points for the development of specific treatments that reduces the global burden of C. trachomatis infections.

Ort, förlag, år, upplaga, sidor
Elsevier, 2018
Nyckelord
2, 3-diaryl-2, 3-dihydrobenzofuran, 2, 3-diaryl-benzofuran, Antibacterial, Benzofuran, Chlamydia
Nationell ämneskategori
Organisk kemi Biologiska vetenskaper
Identifikatorer
urn:nbn:se:umu:diva-143062 (URN)10.1016/j.ejmech.2017.11.099 (DOI)000428216700089 ()29232584 (PubMedID)
Forskningsfinansiär
Stiftelsen för strategisk forskning (SSF), SB12-0022Vetenskapsrådet, 621-2014-4670
Tillgänglig från: 2017-12-18 Skapad: 2017-12-18 Senast uppdaterad: 2018-08-24Bibliografiskt granskad
2. Identification of Inhibitors of Pseudomonas aeruginosa Exotoxin-S ADP-Ribosyltransferase Activity
Öppna denna publikation i ny flik eller fönster >>Identification of Inhibitors of Pseudomonas aeruginosa Exotoxin-S ADP-Ribosyltransferase Activity
Visa övriga...
2016 (Engelska)Ingår i: Journal of Biomolecular Screening, ISSN 1087-0571, E-ISSN 1552-454X, Vol. 21, nr 6, s. 590-595Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

The gram-negative bacterium Pseudomonas aeruginosa is an opportunistic pathogen associated with drug resistance complications and, as such, an important object for drug discovery efforts. One attractive target for development of therapeutics is the ADP-ribosyltransferase Exotoxin-S (ExoS), an early effector of the type III secretion system that is delivered into host cells to affect their transcription pattern and cytoskeletal dynamics. The purpose of this study was to formulate a real-time assay of purified recombinant ExoS activity for high-throughput application. We characterized the turnover kinetics of the fluorescent dinucleotide 1,N-6-etheno-NAD+ as co-substrate for ExoS. Further, we found that the toxin relied on any of five tested isoforms of human 14-3-3 to modify vH-Ras and the Rho-family GTPases Rac1, -2, and -3 and RhoC. We then used 14-3-3-stimulated ExoS modification of vH-Ras to screen a collection of low-molecular-weight compounds selected to target the poly-ADP ribose polymerase family and identified 3-(4-oxo-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-y l)propanoic acid as an ExoS inhibitor with micromolar potency. Thus, we present an optimized method to screen for inhibitors of ExoS activity that is amenable to high-throughput format and an intermediate affinity inhibitor that can serve both as assay control and as a starting point for further development.

Nyckelord
ADP-ribosylation, bacterial toxins, drug discovery, enzyme inhibitors, Pseudomonas aeruginosa
Nationell ämneskategori
Biokemi och molekylärbiologi Läkemedelskemi
Identifikatorer
urn:nbn:se:umu:diva-124333 (URN)10.1177/1087057116629923 (DOI)000379694900007 ()26850638 (PubMedID)
Tillgänglig från: 2016-09-22 Skapad: 2016-08-04 Senast uppdaterad: 2018-08-24Bibliografiskt granskad
3. Structure–activity relationships for inhibitors of Pseudomonas aeruginosa exoenzyme S ADP-ribosyltransferase activity
Öppna denna publikation i ny flik eller fönster >>Structure–activity relationships for inhibitors of Pseudomonas aeruginosa exoenzyme S ADP-ribosyltransferase activity
Visa övriga...
2018 (Engelska)Ingår i: European Journal of Medicinal Chemistry, ISSN 0223-5234, E-ISSN 1768-3254, Vol. 143, s. 568-576Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

During infection, the Gram-negative opportunistic pathogen Pseudomonas aeruginosa employs its type III secretion system to translocate the toxin exoenzyme S (ExoS) into the eukaryotic host cell cytoplasm. ExoS is an essential in vivo virulence factor that enables P. aeruginosa to avoid phagocytosis and eventually kill the host cell. ExoS elicits its pathogenicity mainly via ADP-ribosyltransferase (ADPRT) activity. We recently identified a new class of ExoS ADPRT inhibitors with in vitro IC50 of around 20 μM in an enzymatic assay using a recombinant ExoS ADPRT domain. Herein, we report structure-activity relationships of this compound class by comparing a total of 51 compounds based on a thieno [2,3-d]pyrimidin-4(3H)-one and 4-oxo-3,4-dihydroquinazoline scaffolds. Improved inhibitors with in vitro IC50 values of 6 μM were identified. Importantly, we demonstrated that the most potent inhibitors block ADPRT activity of native full-length ExoS secreted by viable P. aeruginosa with an IC50 value of 1.3 μM in an enzymatic assay. This compound class holds promise as starting point for development of novel antibacterial agents.

Ort, förlag, år, upplaga, sidor
Elsevier, 2018
Nyckelord
2-Aminobenzamide, ADP-Ribosyltransferase, Bacterial exotoxins, ExoS, Pseudomonas aeruginosa, Quinazolines, Type III secretion
Nationell ämneskategori
Organisk kemi Cell- och molekylärbiologi
Identifikatorer
urn:nbn:se:umu:diva-143429 (URN)10.1016/j.ejmech.2017.11.036 (DOI)000428216700046 ()29207339 (PubMedID)
Tillgänglig från: 2017-12-23 Skapad: 2017-12-23 Senast uppdaterad: 2018-08-24Bibliografiskt granskad
4. Identification of small molecules blocking the Pseudomonas aeruginosa type III secretion system protein PcrV
Öppna denna publikation i ny flik eller fönster >>Identification of small molecules blocking the Pseudomonas aeruginosa type III secretion system protein PcrV
Visa övriga...
(Engelska)Manuskript (preprint) (Övrigt vetenskapligt)
Abstract [en]

Pseudomonas aeruginosa is an opportunistic bacterial pathogen that employs the type III secretion system (T3SS) during acute phase of infection to translocate cytotoxins into the host cell cytoplasm. PcrV, known as the V-antigen, is a T3S protein that facilitates the integration of the translocators into the eukaryotic cell membrane. In this study, we report surface plasmon resonance screening to identify small molecule binders of PcrV. A follow up primary structure-activity relationship analysis resulted in anti-virulence PcrV binders that protect macrophages in a  P. aeruginosa cell-based infection assay.

Nyckelord
Pseudomonas aeruginosa, type III secretion, PcrV, surface plasmon resonance, screening, small molecules, macrophages
Nationell ämneskategori
Naturvetenskap
Forskningsämne
organisk kemi; biologi
Identifikatorer
urn:nbn:se:umu:diva-150969 (URN)
Forskningsfinansiär
Stiftelsen för strategisk forskning (SSF), SB12-0022
Tillgänglig från: 2018-08-21 Skapad: 2018-08-21 Senast uppdaterad: 2018-08-21

Open Access i DiVA

fulltext(22753 kB)94 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 22753 kBChecksumma SHA-512
6975571528673abf326753ebcff790d94bbdc54f37b6404ae819575bce196ac1f3e1477a9c0bdc250e66c42d37bdd3ac0d2205aefa916fc4e2279aee0053a7d9
Typ fulltextMimetyp application/pdf
spikblad(115 kB)15 nedladdningar
Filinformation
Filnamn FULLTEXT02.pdfFilstorlek 115 kBChecksumma SHA-512
87f9d1287a47ce1a75383b15b67a9adf03b193f77c48d1c36cf6331eb5912523d7789d3054755236bc8207b668b8840b46f469352fd64c855d41612591c1fb16
Typ spikbladMimetyp application/pdf

Personposter BETA

Saleeb, Michael

Sök vidare i DiVA

Av författaren/redaktören
Saleeb, Michael
Av organisationen
Kemiska institutionen
NaturvetenskapOrganisk kemi

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 109 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

isbn
urn-nbn

Altmetricpoäng

isbn
urn-nbn
Totalt: 225 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf